
Reset all filters
01 2Roctavian
Valoctocogene Roxaparvovec-rvox
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 4
2022 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2024 Revenue in Millions : 26
2023 Revenue in Millions : 4
Growth (%) : 643